Published in Antimicrob Agents Chemother on September 01, 2006
RNase A ribonucleases and host defense: an evolving story. J Leukoc Biol (2008) 1.34
Human antimicrobial peptides and proteins. Pharmaceuticals (Basel) (2014) 1.23
Mouse beta-defensin-14, an antimicrobial ortholog of human beta-defensin-3. Antimicrob Agents Chemother (2008) 1.07
RNase 7 contributes to the cutaneous defense against Enterococcus faecium. PLoS One (2009) 1.06
Midkine in host defence. Br J Pharmacol (2014) 0.88
Ribonucleases 6 and 7 have antimicrobial function in the human and murine urinary tract. Kidney Int (2014) 0.86
In silico prediction and in vitro characterization of multifunctional human RNase3. Biomed Res Int (2013) 0.82
The Ribonuclease A Superfamily in Humans: Canonical RNases as the Buttress of Innate Immunity. Int J Mol Sci (2016) 0.80
RNase 7 in Cutaneous Defense. Int J Mol Sci (2016) 0.78
Exploring the mechanisms of action of human secretory RNase 3 and RNase 7 against Candida albicans. Microbiologyopen (2016) 0.76
A study of ribonuclease activity in venom of vietnam cobra. J Anim Sci Technol (2017) 0.75
Improved prediction of signal peptides: SignalP 3.0. J Mol Biol (2004) 48.40
Antimicrobial peptides of multicellular organisms. Nature (2002) 23.50
Defensins: antimicrobial peptides of innate immunity. Nat Rev Immunol (2003) 11.11
Isolation and characterization of human beta -defensin-3, a novel human inducible peptide antibiotic. J Biol Chem (2000) 6.19
Angiogenins: a new class of microbicidal proteins involved in innate immunity. Nat Immunol (2003) 6.17
Dermcidin: a novel human antibiotic peptide secreted by sweat glands. Nat Immunol (2001) 2.29
RNase 7, a novel innate immune defense antimicrobial protein of healthy human skin. J Biol Chem (2002) 1.99
The role of cathelicidins in the innate host defenses of mammals. Curr Issues Mol Biol (2005) 1.94
The mammalian ionic environment dictates microbial susceptibility to antimicrobial defense peptides. FASEB J (2006) 1.66
Antimicrobial polypeptides. J Leukoc Biol (2003) 1.46
Histatins: antimicrobial peptides with therapeutic potential. J Pharm Pharmacol (2004) 1.39
Burkholderia is highly resistant to human Beta-defensin 3. Antimicrob Agents Chemother (2003) 1.29
RNase 8, a novel RNase A superfamily ribonuclease expressed uniquely in placenta. Nucleic Acids Res (2002) 1.28
Human RNase 7: a new cationic ribonuclease of the RNase A superfamily. Nucleic Acids Res (2003) 1.22
The eosinophil ribonucleases. Cell Mol Life Sci (1998) 1.04
Antimicrobial psoriasin (S100A7) protects human skin from Escherichia coli infection. Nat Immunol (2004) 3.19
NF-kappaB- and AP-1-mediated induction of human beta defensin-2 in intestinal epithelial cells by Escherichia coli Nissle 1917: a novel effect of a probiotic bacterium. Infect Immun (2004) 2.47
Detection of diverse bacterial signatures in atherosclerotic lesions of patients with coronary heart disease. Circulation (2006) 2.41
Cutting edge: critical role for mesothelial cells in necrosis-induced inflammation through the recognition of IL-1 alpha released from dying cells. J Immunol (2008) 2.13
NOD2/CARD15 mediates induction of the antimicrobial peptide human beta-defensin-2. J Biol Chem (2005) 2.06
Co-regulation and interdependence of the mammalian epidermal permeability and antimicrobial barriers. J Invest Dermatol (2007) 2.02
Cytosolic DNA triggers inflammasome activation in keratinocytes in psoriatic lesions. Sci Transl Med (2011) 1.74
Degradation by stratum corneum proteases prevents endogenous RNase inhibitor from blocking antimicrobial activities of RNase 5 and RNase 7. J Invest Dermatol (2009) 1.70
RNase 7 protects healthy skin from Staphylococcus aureus colonization. J Invest Dermatol (2010) 1.69
Epidermal EGFR controls cutaneous host defense and prevents inflammation. Sci Transl Med (2013) 1.69
Uncovering the evolutionary history of innate immunity: the simple metazoan Hydra uses epithelial cells for host defence. Dev Comp Immunol (2008) 1.55
Production of endogenous antibiotics in articular cartilage. Arthritis Rheum (2004) 1.55
Duration of fecal shedding of Shiga toxin-producing Escherichia coli O104:H4 in patients infected during the 2011 outbreak in Germany: a multicenter study. Clin Infect Dis (2013) 1.46
The novel human beta-defensin-3 is widely expressed in oral tissues. Eur J Oral Sci (2002) 1.43
UV-B radiation induces the expression of antimicrobial peptides in human keratinocytes in vitro and in vivo. J Allergy Clin Immunol (2009) 1.31
Burkholderia is highly resistant to human Beta-defensin 3. Antimicrob Agents Chemother (2003) 1.29
The battle against multi-resistant strains: Renaissance of antimicrobial essential oils as a promising force to fight hospital-acquired infections. J Craniomaxillofac Surg (2009) 1.26
Ribonuclease 7 is a potent antimicrobial peptide within the human urinary tract. Kidney Int (2011) 1.25
Expression of human beta-defensins 1 and 2 in kidneys with chronic bacterial infection. BMC Infect Dis (2002) 1.20
Recommended test panel for differentiation of Klebsiella species on the basis of a trilateral interlaboratory evaluation of 18 biochemical tests. J Clin Microbiol (2004) 1.20
Influence of polymorphisms in the NOD1/CARD4 and NOD2/CARD15 genes on the clinical outcome of Helicobacter pylori infection. Cell Microbiol (2006) 1.18
The antimicrobial protein psoriasin (S100A7) is upregulated in atopic dermatitis and after experimental skin barrier disruption. J Invest Dermatol (2008) 1.18
Impaired phagosomal maturation in neutrophils leads to periodontitis in lysosomal-associated membrane protein-2 knockout mice. J Immunol (2008) 1.15
Psoriasin (S100A7) is significantly up-regulated in human epithelial skin tumours. J Cancer Res Clin Oncol (2006) 1.15
Rapid emergence of resistance to linezolid during linezolid therapy of an Enterococcus faecium infection. Antimicrob Agents Chemother (2006) 1.14
Antitumor activity of the antimicrobial peptide magainin II against bladder cancer cell lines. Eur Urol (2006) 1.12
Penicillin compared with other advanced broad spectrum antibiotics regarding antibacterial activity against oral pathogens isolated from odontogenic abscesses. J Craniomaxillofac Surg (2008) 1.10
Role of glial cells in the functional expression of LL-37/rat cathelin-related antimicrobial peptide in meningitis. J Neuropathol Exp Neurol (2008) 1.07
Mouse beta-defensin-14, an antimicrobial ortholog of human beta-defensin-3. Antimicrob Agents Chemother (2008) 1.07
Comparative in vitro activities of the novel antibacterial finafloxacin against selected Gram-positive and Gram-negative bacteria tested in Mueller-Hinton broth and synthetic urine. Antimicrob Agents Chemother (2011) 1.06
RNase 7 contributes to the cutaneous defense against Enterococcus faecium. PLoS One (2009) 1.06
Pseudomonas aeruginosa- and IL-1beta-mediated induction of human beta-defensin-2 in keratinocytes is controlled by NF-kappaB and AP-1. J Invest Dermatol (2006) 1.03
Surfactant protein D binds selectively to Klebsiella pneumoniae lipopolysaccharides containing mannose-rich O-antigens. J Immunol (2002) 1.02
Human beta-defensin 2 and beta-defensin 3 chimeric peptides reveal the structural basis of the pathogen specificity of their parent molecules. Antimicrob Agents Chemother (2010) 1.01
Hydramacin-1, structure and antibacterial activity of a protein from the basal metazoan Hydra. J Biol Chem (2008) 1.00
Mechanical and metabolic injury to the skin barrier leads to increased expression of murine β-defensin-1, -3, and -14. J Invest Dermatol (2010) 0.99
Antimicrobial peptides of the Cecropin-family show potent antitumor activity against bladder cancer cells. BMC Urol (2008) 0.98
Platelets display potent antimicrobial activity and release human beta-defensin 2. Platelets (2011) 0.96
Highly complex peptide aggregates of the S100 fused-type protein hornerin are present in human skin. J Invest Dermatol (2008) 0.95
Klebsiella oxytoca: opportunistic infections in laboratory rodents. Lab Anim (2008) 0.94
Urinary pharmacokinetics and bactericidal activity of finafloxacin (200 and 800 mg) in healthy volunteers receiving a single oral dose. Chemotherapy (2011) 0.94
Activity of the novel peptide arminin against multiresistant human pathogens shows the considerable potential of phylogenetically ancient organisms as drug sources. Antimicrob Agents Chemother (2009) 0.94
The human antimicrobial protein psoriasin acts by permeabilization of bacterial membranes. Dev Comp Immunol (2009) 0.93
Focal targeting by human β-defensin 2 disrupts localized virulence factor assembly sites in Enterococcus faecalis. Proc Natl Acad Sci U S A (2013) 0.93
Antimicrobial RNases in cutaneous defense. J Innate Immun (2012) 0.93
Human beta-defensin 3 mediates tissue remodeling processes in articular cartilage by increasing levels of metalloproteinases and reducing levels of their endogenous inhibitors. Arthritis Rheum (2005) 0.92
CD9 clustering and formation of microvilli zippers between contacting cells regulates virus-induced cell fusion. Traffic (2008) 0.90
The angiogenesis inhibitor thrombospondin-1 inhibits acute cutaneous hypersensitivity reactions. J Invest Dermatol (2009) 0.90
Multiple trauma induces serum production of host defence peptides. Injury (2011) 0.90
Nasal carriage of Staphylococcus aureus and endonasal activity in Wegener s granulomatosis as compared to rheumatoid arthritis and chronic Rhinosinusitis with nasal polyps. Clin Exp Rheumatol (2010) 0.89
Thrombocytes are effectors of the innate immune system releasing human beta defensin-3. Injury (2011) 0.89
The expression of the beta-defensins hBD-2 and hBD-3 is differentially regulated by NF-kappaB and MAPK/AP-1 pathways in an in vitro model of Candida esophagitis. BMC Immunol (2009) 0.89
Expression and regulation of antimicrobial peptide rCRAMP after bacterial infection in primary rat meningeal cells. J Neuroimmunol (2009) 0.89
Differential expression pattern of antimicrobial peptides in nasal mucosa and secretion. Rhinology (2011) 0.88
Expression and regulation of antimicrobial peptide psoriasin (S100A7) at the ocular surface and in the lacrimal apparatus. Invest Ophthalmol Vis Sci (2011) 0.87
IL-17A and IFN-γ synergistically induce RNase 7 expression via STAT3 in primary keratinocytes. PLoS One (2013) 0.87
Extracellular cathepsin K exerts antimicrobial activity and is protective against chronic intestinal inflammation in mice. Gut (2012) 0.86
Novel anti-inflammatory properties of the angiogenesis inhibitor vasostatin. J Invest Dermatol (2006) 0.86
The formyl peptide receptor like-1 and scavenger receptor MARCO are involved in glial cell activation in bacterial meningitis. J Neuroinflammation (2011) 0.86
Lipid-specific membrane activity of human beta-defensin-3. Biochemistry (2006) 0.86
Paraoxonase 2 acts as a quorum sensing-quenching factor in human keratinocytes. J Invest Dermatol (2012) 0.86
Activity of human beta-defensins 2 and 3 against ESBL-producing Klebsiella strains. J Antimicrob Chemother (2006) 0.86
Differential expression and in vivo secretion of the antimicrobial peptides psoriasin (S100A7), RNase 7, human beta-defensin-2 and -3 in healthy human skin. Exp Dermatol (2013) 0.86
S100A7/psoriasin expression in the human lung: unchanged in patients with COPD, but upregulated upon positive S. aureus detection. BMC Pulm Med (2011) 0.85
Differential expression of antimicrobial peptides in margins of chronic wounds. Exp Dermatol (2010) 0.85
Differential suppression of epidermal antimicrobial protein expression in atopic dermatitis and in EFAD mice by pimecrolimus compared to corticosteroids. Exp Dermatol (2011) 0.85
Antimicrobial peptides in oral cancer. Curr Pharm Des (2007) 0.84
Functional expression of the intracellular pattern recognition receptor NOD1 in human keratinocytes. J Invest Dermatol (2009) 0.83
Dichotomous selection of high-level oxacillin resistance in Staphylococcus aureus by fluoroquinolones. Int J Antimicrob Agents (2010) 0.83
Human beta-defensin-2 in oral cancer with opportunistic Candida infection. Anticancer Res (2004) 0.83
Noncapsulated Klebsiella pneumoniae bearing mannose-containing O antigens is rapidly eradicated from mouse lung and triggers cytokine production by macrophages following opsonization with surfactant protein D. Infect Immun (2005) 0.83
IL-1β and ADAM17 are central regulators of β-defensin expression in Candida esophagitis. Am J Physiol Gastrointest Liver Physiol (2011) 0.83
Antimicrobial peptides in nasal secretion and mucosa with respect to Staphylococcus aureus colonization in chronic rhinosinusitis with nasal polyps. Rhinology (2011) 0.83
Macin family of antimicrobial proteins combines antimicrobial and nerve repair activities. J Biol Chem (2012) 0.82
A novel horse alpha-defensin: gene transcription, recombinant expression and characterization of the structure and function. Biochem J (2007) 0.81
The ongoing battle against multi-resistant strains: in-vitro inhibition of hospital-acquired MRSA, VRE, Pseudomonas, ESBL E. coli and Klebsiella species in the presence of plant-derived antiseptic oils. J Craniomaxillofac Surg (2012) 0.81
Oesophageal defensin expression during Candida infection and reflux disease. Scand J Gastroenterol (2005) 0.81
Psoriasin: key molecule of the cutaneous barrier? J Dtsch Dermatol Ges (2011) 0.81
Antiserum against Raoultella terrigena ATCC 33257 identifies a large number of Raoultella and Klebsiella clinical isolates as serotype O12. Innate Immun (2010) 0.81
Antimicrobial activity of bovine psoriasin. Vet Microbiol (2008) 0.80
The antimicrobial peptide Ci-MAM-A24 is highly active against multidrug-resistant and anaerobic bacteria pathogenic for humans. Int J Antimicrob Agents (2010) 0.80
Aberrant cytokine pattern of the nasal mucosa in granulomatosis with polyangiitis. Arthritis Res Ther (2012) 0.79